Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.

about

Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT.

Item

http://www.wikidata.org/entity/Q38690098

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Influence of CYP2C19 Genotypes ...... ical Patients after Allo-HSCT.

@en

type

Item

label

Influence of CYP2C19 Genotypes ...... ical Patients after Allo-HSCT.

@en

prefLabel

Influence of CYP2C19 Genotypes ...... ical Patients after Allo-HSCT.

@en

P1476

Influence of CYP2C19 Genotypes ...... gical Patients after Allo-HSCT

@en

P2093

Andrzej Dryś

http://www.w3.org/2001/XMLSchema#string

Anna Wiela-Hojeńska

http://www.w3.org/2001/XMLSchema#string

Donata Urbaniak-Kujda

http://www.w3.org/2001/XMLSchema#string

Jarosław Dybko

http://www.w3.org/2001/XMLSchema#string

Magdalena Hurkacz

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report

CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.

Variability of voriconazole plasma concentrations after allogeneic hematopoietic stem cell transplantation: impact of cytochrome p450 polymorphisms and comedications on initial and subsequent trough levels

Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction

Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use.

Clinically relevant drug-drug interactions between antiretrovirals and antifungals

Therapeutic Drug Monitoring and Genotypic Screening in the Clinical Use of Voriconazole.

Pharmacokinetics of intravenous voriconazole in obese patients: implications of CYP2C19 homozygous poor metabolizer genotype.

Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events.

P2888

s12253-017-0264-9

P304

541-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12253-017-0264-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tomasz Wróbel

Beata M Sienkiewicz

P577

2017-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28685218

http://www.w3.org/2001/XMLSchema#string

P932

5972163

http://www.w3.org/2001/XMLSchema#string